School of Pharmacy, China Medical University, Shenyang, China.
Chem Biol Drug Des. 2018 Feb;91(2):526-533. doi: 10.1111/cbdd.13114. Epub 2017 Oct 18.
A series of 5-(4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl)benzonitrile derivatives (1a-p) was designed, synthesized, and identified as xanthine oxidase inhibitors with micromolar level potencies. Among them, the most promising compounds 1j and 1k were obtained with IC values of 8.1 and 6.7 μm, respectively. The Lineweaver-Burk plot revealed that compound 1k acted as a mixed-type xanthine oxidase inhibitor. SAR analysis revealed that a carbon atom occupying the X position is not as effective as a nitrogen atom, and an iso-pentyloxy or a cyclopentyloxy at the 2-position of benzonitrile moiety will benefit the inhibitory potency. The basis of xanthine oxidase inhibition by 1k was rationalized by molecular modeling studies.
设计、合成并鉴定了一系列 5-(4-(吡啶-4-基)-1H-1,2,3-三唑-1-基)苯甲腈衍生物(1a-p),它们是具有微摩尔水平效力的黄嘌呤氧化酶抑制剂。其中,最有前途的化合物 1j 和 1k 的 IC 值分别为 8.1 和 6.7μm。Lineweaver-Burk 作图表明,化合物 1k 为混合类型黄嘌呤氧化酶抑制剂。SAR 分析表明,占据 X 位置的碳原子不如氮原子有效,苯甲腈部分 2-位的异戊氧基或环戊氧基有利于抑制效力。通过分子建模研究,合理推断了 1k 抑制黄嘌呤氧化酶的基础。